These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4514392)

  • 1. One daily dose of diphenylhydantoin (DPH) to patients with epilepsy.
    Strandjord RE; Johannessen SI
    Acta Neurol Scand Suppl; 1972; 51():499-500. PubMed ID: 4514392
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum diphenylhydantoin in epileptic patients (preliminary report)].
    Radzikowska B; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1977; 11(5):551-4. PubMed ID: 593505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One daily dose of diphenylhydantoin for patients with epilepsy.
    Strandjord RE; Johannessen SI; Halpern LM
    Epilepsia; 1974 Sep; 15(3):317-27. PubMed ID: 4527914
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies of the effect of 5,5-diphenylhydantoin on the bioelectric activity of the brain in epilepsy].
    Domzal T; Gajkowski K
    Neurol Neurochir Pol; 1971; 5(3):301-6. PubMed ID: 5000628
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma diphenylhydantoin values after oral and intramuscular administration of diphenylhydantoin.
    Serrano EE; Roye DB; Hammer RH; Wilder BJ
    Neurology; 1973 Mar; 23(3):311-7. PubMed ID: 4735181
    [No Abstract]   [Full Text] [Related]  

  • 6. A method for shifting from oral to intramuscular diphenylhydantoin administration.
    Wilder BJ; Serrano EE; Ramsey E; Buchanan RA
    Clin Pharmacol Ther; 1974 Sep; 16(3):507-13. PubMed ID: 4411662
    [No Abstract]   [Full Text] [Related]  

  • 7. Diphenylhydantoin and epilepsy management.
    Easton JD
    Ann Intern Med; 1972 Sep; 77(3):421-3. PubMed ID: 5053732
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbamazepine (Tegretol) as an anticonvulsant. A controlled double-blind comparison with diphenylhydantoin (Dilantin).
    Troupin AS; Green JR; Halpern LM
    Acta Neurol Scand Suppl; 1975; 60():13-26. PubMed ID: 1103550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of anticonvulsive treatment on drug elimination in man. Induction of liver hydroxylating enzyme system by diphenylhydantoin and carbamazepine].
    Petruch F; Schüppel RV
    Bibl Psychiatr; 1975; (151):76-81. PubMed ID: 1156351
    [No Abstract]   [Full Text] [Related]  

  • 10. [5,5-Diphenylhydantoin (hydantoinal Polfa)].
    Pakszys W
    Neurol Neurochir Pol; 1973; 7(1):79-84. PubMed ID: 4570505
    [No Abstract]   [Full Text] [Related]  

  • 11. Diphenylhydantoin potency and plasma protein binding.
    Shoeman DW; Azarnoff DL
    J Pharmacol Exp Ther; 1975 Oct; 195(1):84-6. PubMed ID: 1181407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phenytoin--blood levels and clinical aspects].
    Strandfjord RE; Johannessen SI
    Tidsskr Nor Laegeforen; 1973 Feb; 93(6):395-8. PubMed ID: 4698026
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacodynamic aspects of phenobarbital (PB) and diphenylhydantoin (DPH). Correlations with clinical findings].
    Denegri M; Luciano L
    Rev Neuropsychiatr Infant; 1972; 20(3):375-83. PubMed ID: 5055027
    [No Abstract]   [Full Text] [Related]  

  • 14. Inadequate serum levels after intramuscular administration of diphenylhydantoin.
    Wilensky AJ; Lowden JA
    Neurology; 1973 Mar; 23(3):318-24. PubMed ID: 4735182
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Drug levels in epilepsy.
    Lancet; 1975 Aug; 2(7928):264-7. PubMed ID: 49804
    [No Abstract]   [Full Text] [Related]  

  • 16. [Plasma diphenylhydantoin concentration in epileptic patients].
    Herishanu Y; Eylath U
    Harefuah; 1974 Sep; 87(6):251-3. PubMed ID: 4442797
    [No Abstract]   [Full Text] [Related]  

  • 17. [Daily plasma fluctuations of diphenylhydantoin in patients treated with diphenylhydantoin and sodium valproate].
    Pisani F; Di Perri R
    Acta Neurol Quad (Napoli); 1981; 42():61-3. PubMed ID: 6791452
    [No Abstract]   [Full Text] [Related]  

  • 18. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
    Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
    Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dosage increments on blood phenytoin concentrations.
    Bochner F; Hooper WD; Tyrer JH; Eadie MJ
    J Neurol Neurosurg Psychiatry; 1972 Dec; 35(6):873-6. PubMed ID: 4647859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of diphenylhydantoin (DPH) and tolbutamide in man.
    Wesseling H; Mols-Thürkow I
    Eur J Clin Pharmacol; 1975; 8(1):75-8. PubMed ID: 1233204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.